跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 章賢
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0003-2134-1309
電子郵件
862077
tmuh.org
tw
h-index
189
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2012
2025
每年研究成果
概覽
指紋
網路
研究成果
(14)
類似的個人檔案
(6)
指紋
查看啟用 Chang-Hsien Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Metabolic Syndrome
77%
Preventive Medicine
73%
Health Care
66%
Medical Examination
55%
Chronic Kidney Disease
44%
Electronic Patient Record
44%
Obesity
33%
Diabetes
33%
Systematic Review
33%
Meta-Analysis
33%
Malignant Neoplasm
33%
End Stage Liver Disease
33%
Supplementation
33%
Probiotic Agent
33%
4 Iodo 2,5 Dimethoxyamphetamine
33%
Gestational Diabetes
33%
Biocompatible Material
33%
Intervertebral Disk Degeneration
33%
Neonatal Infant
33%
Birth Weight
33%
Diabetes Mellitus
33%
Polygenic Risk Score
33%
Personalized Medicine
33%
Blood Urea Nitrogen
25%
Disease
24%
Chronic Liver Disease
22%
Prothrombin Time
22%
Diseases
22%
Genetic Risk
22%
Phenome
22%
Retrospective Cohort Study
22%
FibroScan
16%
Diagnosis
15%
Logistic Regression Analysis
15%
Body Mass Index
12%
Nucleus Pulposus
11%
In Vitro
11%
Reactive Oxygen Species
11%
Healthcare Practitioner
11%
Mortality Rate
11%
Creatinine
11%
Proportional Hazards Model
11%
Medical Record
11%
Bilirubin
11%
Awareness
11%
Odds Ratio
11%
Healthy Lifestyle
11%
Health Status
11%
Medical Informatics
11%
Telemedicine
11%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Random Forest
83%
Decision Trees
50%
Blood Urea Nitrogen
50%
Waist Circumference
50%
Glycated Hemoglobin
50%
Glycosylated Hemoglobin
33%
Supervised Machine Learning
33%
Genomics
33%
Unsupervised Machine Learning
33%
Kidney Function
33%
Body Mass
33%
Polygenic Score
33%
Prothrombin Time
33%
Triacylglycerol Level
33%
Glucose Blood Level
33%
Medical Record
16%
Genetics
16%
Creatinine
16%
Tree
16%
Hyperglycemia
16%
Alanine Aminotransferase Blood Level
16%
Aspartate Aminotransferase Blood Level
16%
Mortality Rate
16%
Bilirubin
16%
Genetic Risk
16%
HDL-Cholesterol
16%
Decision Making
16%
Liver Function
16%
Principal Component Analysis
16%
C-Reactive Protein
16%
High Risk Population
16%
Transaminase
16%
Multivariate Analysis
16%
Autoimmunity
8%
Electronic Medical Record
8%
Genetic Determinism
8%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
47%
Tree
44%
Randomized Controlled Trial
40%
Obesity
33%
Biomaterial
33%
Chronic Kidney Failure
33%
End Stage Liver Disease
33%
Malignant Neoplasm
33%
Intervertebral Disk Degeneration
33%
Pregnancy Diabetes Mellitus
33%
Metabolic Syndrome X
33%
Probiotic Agent
33%
Diabetes Mellitus
33%
Urate
33%
Hyperuricemia
33%
Disease
30%
Ureaplasma
25%
Prothrombin
22%
Chronic Liver Disease
22%
Xanthine Oxidase Inhibitor
14%
Adverse Event
14%
Creatinine
11%
Bilirubin
11%
Mortality Rate
11%
C Reactive Protein
11%
Febuxostat
11%
Reactive Oxygen Metabolite
9%
Placebo
7%
Lesinurad
7%
Topiroxostat
7%
Terminalia bellirica
7%
Hemoglobin A1c
5%
